Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 2,086,000 | 2,065,000 | 2,026,000 | 2,110,000 | 1,620,000 |
| Cost of Goods | 568,000 | 526,000 | 630,000 | 677,000 | 374,000 |
| Gross Profit | 1,518,000 | 1,539,000 | 1,396,000 | 1,433,000 | 1,246,000 |
| Operating Expenses | 1,236,000 | 1,255,000 | 1,201,000 | 5,358,000 | 749,000 |
| Operating Income | 282,000 | 284,000 | 195,000 | -3,925,000 | 497,000 |
| Interest Expense | 141,000 | 144,000 | 143,000 | 111,000 | 37,000 |
| Other Income | 18,000 | 29,000 | -1,000 | -150,000 | -29,000 |
| Pre-tax Income | 159,000 | 169,000 | 51,000 | -4,186,000 | 431,000 |
| Income Tax | 39,000 | -108,000 | -25,000 | 76,000 | 99,000 |
| Net Income Continuous | 120,000 | 277,000 | 76,000 | -4,262,000 | 332,000 |
| Net Income | $120,000 | $277,000 | $76,000 | $-4,262,000 | $332,000 |
| EPS Basic Total Ops | 0.08 | -0.05 | 0.05 | -3.21 | 0.40 |
| EPS Basic Continuous Ops | 0.08 | -0.05 | 0.05 | -3.21 | 0.40 |
| EPS Diluted Total Ops | 0.08 | -0.05 | 0.05 | -3.21 | 0.40 |
| EPS Diluted Continuous Ops | 0.08 | -0.05 | 0.05 | -3.21 | 0.40 |
| EBITDA(a) | $282,000 | $284,000 | $195,000 | $-3,925,000 | $497,000 |